FdaApplication

NDA 022360

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHALEON US HOLDINGS LLC
application_typeNDA
approval_date2009-05-18

Products (2)

ProductActive ingredientStrengthDosage form
NICORETTENICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE;ORAL
NICORETTENICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE;ORAL

2 products